作者: Peter H. Byers , Shawna M. Pyott
DOI: 10.1146/ANNUREV-GENET-110711-155608
关键词:
摘要: More than 90% of people who have osteogenesis imperfecta (OI) heterozygous mutations in one the two type I collagen genes, COL1A1 and COL1A2. The effects these changes range from death perinatal period to barely increased fracture frequency reflect different types mutations. Introduction bisphosphonates during past 20 years has targeted bone fragility by decreased resorption. recent recognition biallelic genes that affect either assembly processing or regulation osteoblast development raised hopes for therapies would be specific single-gene disorders identify cellular targets individuals with dominant forms OI. These are yet met, but study recessively inherited OI illuminated details pathways.